198 related articles for article (PubMed ID: 26493122)
1. Association study of androgen signaling pathway genes in polycystic ovary syndrome.
Ketefian A; Jones MR; Krauss RM; Chen YD; Legro RS; Azziz R; Goodarzi MO
Fertil Steril; 2016 Feb; 105(2):467-73.e4. PubMed ID: 26493122
[TBL] [Abstract][Full Text] [Related]
2. Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndrome.
Goodarzi MO; Louwers YV; Taylor KD; Jones MR; Cui J; Kwon S; Chen YD; Guo X; Stolk L; Uitterlinden AG; Laven JS; Azziz R
Fertil Steril; 2011 Apr; 95(5):1736-41.e1-11. PubMed ID: 21300347
[TBL] [Abstract][Full Text] [Related]
3. Impact of rs2414096 polymorphism of CYP19 gene on susceptibility of polycystic ovary syndrome and hyperandrogenism in Kashmiri women.
Ashraf S; Rasool SUA; Nabi M; Ganie MA; Masoodi SR; Amin S
Sci Rep; 2021 Jun; 11(1):12942. PubMed ID: 34155264
[TBL] [Abstract][Full Text] [Related]
4. Association of Calpain (CAPN) 10 (UCSNP-43, rs3792267) gene polymorphism with elevated serum androgens in young women with the most severe phenotype of polycystic ovary syndrome (PCOS).
Anastasia K; Koika V; Roupas ND; Armeni A; Marioli D; Panidis D; George A; Georgopoulos NA
Gynecol Endocrinol; 2015; 31(8):630-4. PubMed ID: 26376770
[TBL] [Abstract][Full Text] [Related]
5. Gene dose effect between a fat mass and obesity-associated polymorphism and body mass index was observed in Korean women with polycystic ovary syndrome but not in control women.
Kim JJ; Choi YM; Hong MA; Kim JM; Hwang SS; Lee GH; Chae SJ; Hwang KR; Yoon SH; Kim SH
Fertil Steril; 2014 Oct; 102(4):1143-1148.e2. PubMed ID: 25086788
[TBL] [Abstract][Full Text] [Related]
6. Association of SNPs in the FK-506 binding protein (FKBP5) gene among Han Chinese women with polycystic ovary syndrome.
Ma X; Wang Z; Zhang C; Bian Y; Zhang X; Liu X; Cao Y; Zhao Y
BMC Med Genomics; 2022 Jul; 15(1):149. PubMed ID: 35787810
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood-derived cytokine gene polymorphisms and metabolic profile in women with polycystic ovary syndrome.
Sóter MO; Ferreira CN; Sales MF; Candido AL; Reis FM; Milagres KS; Ronda C; Silva IO; Sousa MO; Gomes KB
Cytokine; 2015 Dec; 76(2):227-235. PubMed ID: 26141422
[TBL] [Abstract][Full Text] [Related]
8. Expression of FKBP52 in the ovaries of PCOS rats.
Song S; Tan Y
Int J Mol Med; 2019 Feb; 43(2):868-878. PubMed ID: 30483787
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism in postinsulin receptor signaling pathway is not associated with polycystic ovary syndrome.
Jones MR; Wilson SG; Mullin BH; Mead R; Dudbridge F; Watts GF; Stuckey BG
Fertil Steril; 2008 Dec; 90(6):2298-303. PubMed ID: 18249389
[TBL] [Abstract][Full Text] [Related]
10. Androgen levels and metabolic parameters are associated with a genetic variant of F13A1 in women with polycystic ovary syndrome.
Schweighofer N; Lerchbaum E; Trummer O; Schwetz V; Pilz S; Pieber TR; Obermayer-Pietsch B
Gene; 2012 Aug; 504(1):133-9. PubMed ID: 22565190
[TBL] [Abstract][Full Text] [Related]
11. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.
Deswal R; Nanda S; Dang AS
Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034
[TBL] [Abstract][Full Text] [Related]
12. PON1 polymorphisms are associated with polycystic ovary syndrome susceptibility, related traits, and PON1 activity in Indian women with the syndrome.
Dadachanji R; Shaikh N; Khavale S; Patil A; Shah N; Mukherjee S
Fertil Steril; 2015 Jul; 104(1):207-16. PubMed ID: 25956367
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism in HSD17B6 is associated with key features of polycystic ovary syndrome.
Jones MR; Italiano L; Wilson SG; Mullin BH; Mead R; Dudbridge F; Watts GF; Stuckey BG
Fertil Steril; 2006 Nov; 86(5):1438-46. PubMed ID: 17070195
[TBL] [Abstract][Full Text] [Related]
14. Variants in the HMG-CoA reductase (HMGCR) gene influence component phenotypes in polycystic ovary syndrome.
Xu N; Taylor KD; Azziz R; Goodarzi MO
Fertil Steril; 2010 Jun; 94(1):255-60.e1-2. PubMed ID: 19327767
[TBL] [Abstract][Full Text] [Related]
15. Increased frequency of the anti-mullerian-inhibiting hormone receptor 2 (AMHR2) 482 A>G polymorphism in women with polycystic ovary syndrome: relationship to luteinizing hormone levels.
Georgopoulos NA; Karagiannidou E; Koika V; Roupas ND; Armeni A; Marioli D; Papadakis E; Welt CK; Panidis D
J Clin Endocrinol Metab; 2013 Nov; 98(11):E1866-70. PubMed ID: 23969185
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovary syndrome susceptibility single nucleotide polymorphisms in women with a single PCOS clinical feature.
Cui L; Li G; Zhong W; Bian Y; Su S; Sheng Y; Shi Y; Wei D; Zhang W; Zhao H; Chen ZJ
Hum Reprod; 2015 Mar; 30(3):732-6. PubMed ID: 25586784
[TBL] [Abstract][Full Text] [Related]
17. Association between genes encoding components of the Leutinizing hormone/Luteinizing hormone-choriogonadotrophin receptor pathway and polycystic ovary syndrome in Egyptian women.
El-Shal AS; Zidan HE; Rashad NM; Abdelaziz AM; Harira MM
IUBMB Life; 2016 Jan; 68(1):23-36. PubMed ID: 26662070
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of the follistatin gene in polycystic ovary syndrome.
Jones MR; Wilson SG; Mullin BH; Mead R; Watts GF; Stuckey BG
Mol Hum Reprod; 2007 Apr; 13(4):237-41. PubMed ID: 17284512
[TBL] [Abstract][Full Text] [Related]
19. The role of epistasis in the etiology of Polycystic Ovary Syndrome among Indian women: SNP-SNP and SNP-environment interactions.
Dasgupta S; Reddy BM
Ann Hum Genet; 2013 Jul; 77(4):288-98. PubMed ID: 23550965
[TBL] [Abstract][Full Text] [Related]
20. Single-nucleotide polymorphism of INS, INSR, IRS1, IRS2, PPAR-G and CAPN10 genes in the pathogenesis of polycystic ovary syndrome.
Thangavelu M; Godla UR; Paul Solomon FD; Maddaly R
J Genet; 2017 Mar; 96(1):87-96. PubMed ID: 28360393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
